secwatch.observer — SEC 8-K summary
======================================

Issuer:     RIGEL PHARMACEUTICALS INC (RIGL)
CIK:        0001034842
Form:       8-K
Filed at:   2022-05-23T23:59:59+00:00
Accession:  0001104659-22-063899
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rigel stockholders approve 2018 Equity Plan amendment adding 5M shares
----------------------------------------------------------------------

- Amended 2018 Equity Incentive Plan increases authorized shares by 5,000,000, effective immediately after stockholder approval on May 19, 2022.
- Vote on amendment: 72,954,216 for, 47,859,509 against, 1,366,196 abstain, 19,065,889 broker non-votes.
- Stockholders elected directors Kamil Ali-Jackson and Jane Wasman to terms expiring at 2025 annual meeting.
- Say-on-pay advisory vote approved: 113,344,916 for, 7,265,856 against, 1,569,149 abstain.
- Ernst & Young ratified as independent auditor for FY2022: 133,170,094 for, 7,845,051 against, 230,665 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1034842/000110465922063899/0001104659-22-063899-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1034842/000110465922063899/tm2216206d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-063899

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer